advertisement

WGA Rescources

Pharmaceutics 9

Showing records 1 to 9 | Display all abstracts in Pharmaceutics

96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Arroyo-García CM
Pharmaceutics 2021; 13:
96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Dammak A; Huete-Toral F
Pharmaceutics 2021; 13:
96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Quinteros D
Pharmaceutics 2021; 13:
96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Carpena-Torres C
Pharmaceutics 2021; 13:
96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Palma SD; Jiménez de Los Santos CJ
Pharmaceutics 2021; 13:
96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Martin-Gil A; Pastrana C
Pharmaceutics 2021; 13:
96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
Moyano JR; Rabasco AM
Pharmaceutics 2021; 13:
96400 From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment
Carracedo G
Pharmaceutics 2021; 13:
96300 Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels
González-Rodríguez ML
Pharmaceutics 2021; 13:

Issue 22-3

Change Issue


advertisement

Bioniko